| Citation Matrix | Glossary HistCite Guide |
|
A gene-expression signature as a predictor of survival in breast cancer. van de Vijver MJ, He YD, van 't Veer LJ, Dai H, Hart AAM, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R NEW ENGLAND JOURNAL OF MEDICINE 347 (25): 1999-2009 DEC 19 2002 and the citing papers. |
Nodes: 110,
Authors: 580,
Sources: 78,
Outer References: 4564
Collection span: 2002 - 2004
View: Overview. Sorted by year, source, volume, issue, page.
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 0 | 20 | 1 2002 NEW ENGLAND JOURNAL OF MEDICINE 347(25):1999-2009
van de Vijver MJ; He YD; van 't Veer LJ; Dai H; Hart AAM; Voskuil DW; Schreiber GJ; Peterse JL; Roberts C; Marton MJ; Parrish M; Atsma D; Witteveen A; Glas A; Delahaye L; van der Velde T; Bartelink H; Rodenhuis S; Rutgers ET; Friend SH; Bernards R A gene-expression signature as a predictor of survival in breast cancer. | 110 | 109 |
| 2 | 1 | 10 | 2 2002 NEW ENGLAND JOURNAL OF MEDICINE 347(25):2067-2068
Kallioniemi A Molecular signatures of breast cancer - Predicting the future. | 5 | 5 |
| 3 | 2 | 17 | 3 2003 ADVANCES IN ANATOMIC PATHOLOGY 10(6):338-346
Master SR; Mies C Gene-expression profiles and breast-cancer prognosis | 0 | 0 |
| 4 | 1 | 134 | 4 2003 ADVANCES IN CANCER RESEARCH, VOL 89 89():35-67
Klein CA The systemic progression of human cancer: A focus on the individual disseminated cancer cell - The unit of selection | 0 | 0 |
| 5 | 1 | 30 | 5 2003 AMERICAN JOURNAL OF SURGERY 186(4):404-408
Jimenez-Lee R; Ham B; Vetto J; Pommier R Breast cancer severity score is an innovative system for prognosis | 0 | 0 |
| 6 | 2 | 112 | 6 2003 ANNALS OF CLINICAL BIOCHEMISTRY 40():612-627
Lips CJM; Lentjes EGWM; Hoppener JWM The spectrum of carcinoid tumours and carcinoid syndromes | 0 | 0 |
| 7 | 1 | 28 | 7 2003 ANNALS OF SURGICAL ONCOLOGY 10(7):718-721
Roukos DH; Kappas AA; Agnantis NJ Perspectives and risks of breast-conservation therapy for breast cancer | 0 | 0 |
| 8 | 1 | 67 | 8 2003 BIOINFORMATICS 19(8):956-965
He YDD; Dai HY; Schadt EE; Cavet G; Edwards SW; Stepaniants SB; Duenwald S; Kleinhanz R; Jones AR; Shoemaker DD; Stoughton RB Microarray standard data set and figures of merit for comparing data processing methods and experiment designs | 1 | 1 |
| 9 | 1 | 16 | 9 2003 BIOLOGICAL PSYCHIATRY 54(4):413-417
Hinkle DA; Eberwine JH Single-cell molecular biology: Implications for diagnosis and treatment of neurologic disease | 0 | 0 |
| 10 | 1 | 38 | 10 2003 BLOOD 102(8):2951-2959
Ross ME; Zhou XD; Song GC; Shurtleff SA; Girtman K; Williams WK; Liu HC; Mahfouz R; Raimondi SC; Lenny N; Patel A; Downing JR Classification of pediatric acute lymphoblastic leukemia by gene expression profiling | 0 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 11 | 2 | 23 | 11 2003 BREAST 12(6):391-396
Viale G Histopathology of primary breast cancer 2003 | 0 | 0 |
| 12 | 1 | 14 | 12 2003 BREAST 12(6):472-474
Wood WC The future of surgery in the treatment of breast cancer | 0 | 0 |
| 13 | 1 | 61 | 13 2003 BREAST 12(6):529-537
Bergh J Best use of adjuvant systemic therapies II, chemotherapy aspects: dose of chemotherapy - cytotoxicity, duration and responsiveness | 0 | 0 |
| 14 | 1 | 43 | 14 2003 BREAST 12(6):543-549
Hayes DF Markers of increased risk for failure of adjuvant therapies | 0 | 0 |
| 15 | 1 | 110 | 15 2003 BREAST 12(6):569-582
Senn HJ; Thurlimann B; Goldhirsch A; Wood WC; Gelber RD; Coates AS Comments on the St. Gallen consensus 2003 on the primary therapy of early breast cancer | 0 | 0 |
| 16 | 1 | 27 | 16 2003 BREAST CANCER RESEARCH 5(3):154-159
de Bono JS; Tolcher AW; Rowinsky EK The future of cytotoxic therapy: selective cytotoxicity based on biology is the key | 0 | 0 |
| 17 | 1 | 73 | 17 2003 BREAST CANCER RESEARCH 5(6):320-328
Jeffrey SS; Pollack JR The diagnosis and management of pre-invasive breast disease - Promise of new technologies in understanding pre-invasive breast lesions | 0 | 2 |
| 18 | 1 | 139 | 18 2003 BREAST CANCER RESEARCH 6(1):1-11
Fata JE; Werb Z; Bissell MJ Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes | 0 | 0 |
| 19 | 1 | 32 | 19 2003 BRITISH JOURNAL OF CANCER 89(10):1914-1919
Zuidervaart W; van der Velden PA; Hurks MH; van Nieuwpoort FA; Out-Luiting CJJ; Singh AD; Frants RR; Jager MJ; Gruis NA Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development | 0 | 0 |
| 20 | 1 | 7 | 20 2003 CANADIAN MEDICAL ASSOCIATION JOURNAL 168(8):949-949
[Anon] The genomification of medicine | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 21 | 1 | 23 | 21 2003 CANCER 98(8):1569-1577
Foulkes WD; Metcalfe K; Hanna W; Lynch HT; Ghadirian P; Tung N; Olopade O; Weber B; McLennan J; Olivotto IA; Sun P; Chappuis PO; Begin LR; Brunet JS; Narod SA Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma | 0 | 1 |
| 22 | 1 | 17 | 22 2003 CANCER 98(10):2133-2143
Michaelson JS; Silverstein M; Sgroi D; Cheongsiatmoy JA; Taghian A; Powell S; Hughes K; Comegno A; Tanabe KK; Smith B The effect of tumor size and lymph node status on breast carcinoma lethality | 0 | 0 |
| 23 | 1 | 16 | 23 2003 CANCER CELL 3(4):307-310
Fearon ER Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer | 0 | 1 |
| 24 | 1 | 19 | 24 2003 CANCER RESEARCH 63(12):3066-3068
Hefler LA; Grimm C; Ackermann S; Malur S; Radjabi-Rahat AR; Leodolter S; Beckmann MW; Zeillinger R; Koelbl H; Tempfer CB An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer | 0 | 0 |
| 25 | 1 | 21 | 25 2003 CANCER RESEARCH 63(18):5679-5684
Woelfle U; Cloos J; Sauter G; Riethdorf L; Janicke F; van Diest P; Brakenhoff R; Pantel K Molecular signature associated with bone marrow micrometastasis in human breast cancer | 0 | 0 |
| 26 | 1 | 57 | 26 2003 CANCER RESEARCH 63(21):7158-7166
Cunliffe HE; Ringner M; Bilke S; Walker RL; Cheung JM; Chen YD; Meltzer PS The gene expression response of breast cancer to growth regulators: Patterns and correlation with tumor expression profiles | 0 | 0 |
| 27 | 1 | 53 | 27 2003 CANCER RESEARCH 63(21):7167-7175
Korkola JE; DeVries S; Fridlyand J; Hwang ES; Estep ALH; Chen YY; Chew KL; Dairkee SH; Jensen RM; Waldman FM Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis | 0 | 0 |
| 28 | 2 | 32 | 28 2003 CANCER RESEARCH 63(22):7641-7645
Muller HM; Widschwendter A; Fiegl H; Ivarsson L; Goebel G; Perkmann E; Marth C; Widschwendter M DNA methylation in serum of breast cancer patients: An independent prognostic marker | 0 | 0 |
| 29 | 1 | 19 | 29 2003 CELL 113(7):821-823
Hynes RO Metastatic potential: Generic predisposition of the primary tumor or rare, metastatic variants - or both? | 1 | 2 |
| 30 | 1 | 55 | 30 2003 CELL PROLIFERATION 36():59-72
Dontu G; Al-Hajj M; Abdallah WA; Clarke MF; Wicha MS Stem cells in normal breast development and breast cancer | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 31 | 1 | 23 | 31 2003 CLINICAL AND EXPERIMENTAL MEDICINE 3(1):1-3
Sevenet N; Cussenot O DNA microarrays in clinical practice: past, present, and future | 0 | 1 |
| 32 | 1 | 28 | 32 2003 CLINICAL CANCER RESEARCH 9(15):5486-5492
Wong YF; Selvanayagam ZE; Wei N; Porter J; Vittal R; Hu R; Lin Y; Liao J; Shih JW; Cheung TH; Lo KWK; Yim SF; Yip SK; Ngong DT; Siu N; Chan LKY; Chan CS; Kong T; Kutlina E; McKinnon RD; Denhardt DT; Chin KV; Chung TKH Expression Genomics of cervical cancer: Molecular classification and prediction of radiotherapy response by DNA microarray | 0 | 0 |
| 33 | 1 | 42 | 33 2003 CLINICAL CANCER RESEARCH 9(16):5980-5987
Lim EH; Aggarwal A; Agasthian T; Wong PS; Tan C; Sim E; Tan L; Goh PS; Wang SC; Khoo KL; Mukherjee A; Khoo SM; Chua G; Nilsson B; Lee KH; Tan P Feasibility of using low-volume tissue samples for gene expression profiling of advanced non-small cell lung cancers | 0 | 0 |
| 34 | 1 | 33 | 34 2003 COMPTES RENDUS BIOLOGIES 326(10-11):1031-1039
Bertucci F; Loriod B; Nasser V; Granjeaud S; Tagett R; Braud AC; Viens P; Houlgatte R; Birnbaum D; Nguyen C Gene expression profiling of breast carcinomas using Nylon DNA arrays | 0 | 0 |
| 35 | 1 | 108 | 35 2003 CROATIAN MEDICAL JOURNAL 44(4):374-385
Gamulin S Impact of molecular medicine on pathophysiology, medical practice, and medical education | 0 | 0 |
| 36 | 3 | 33 | 36 2003 CURRENT OPINION IN BIOTECHNOLOGY 14(6):647-651
Hegde PS; White IR; Debouck C Interplay of transcriptomics and proteomics | 0 | 0 |
| 37 | 1 | 37 | 37 2003 CURRENT OPINION IN CELL BIOLOGY 15(2):213-220
Ciro M; Bracken AP; Helin K Profiling cancer | 0 | 1 |
| 38 | 1 | 64 | 38 2003 CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT 6(3):310-316
Golden JB Prioritizing the human genome: Knowledge management for drug discovery | 0 | 0 |
| 39 | 2 | 13 | 39 2003 CURRENT OPINION IN MOLECULAR THERAPEUTICS 5(6):573-574
McLeod HL; Watson MA Editorial overview - Molecular therapeutics: Are we making progress? | 0 | 0 |
| 40 | 1 | 37 | 40 2003 CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION 12(4):407-414
Hayden PS; El-Meanawy A; Schelling JR; Sedor JR DNA expression analysis: serial analysis of gene expression, microarrays and kidney disease | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 41 | 1 | 58 | 41 2003 ENDOCRINOLOGY 144(10):4562-4574
Frasor J; Danes JM; Komm B; Chang KCN; Lyttle CR; Katzenellenbogen BS Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype | 0 | 1 |
| 42 | 1 | 110 | 42 2003 EUROPEAN JOURNAL OF CANCER 39(9):1199-1215
Baak JPA; Path FRC; Hermsen MAJA; Meijer G; Schmidt J; Janssen EAM Genomics and proteomics in cancer | 1 | 3 |
| 43 | 1 | 85 | 43 2003 EUROPEAN JOURNAL OF CANCER 39(12):1668-1675
Sledge GW; Miller KD Exploiting the hallmarks of cancer: the future conquest of breast cancer | 0 | 0 |
| 44 | 1 | 12 | 44 2003 EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 29(9):701-702
Kelly MR; Kerin MJ The value of axillary lymphadenectomy | 0 | 0 |
| 45 | 1 | 10 | 45 2003 GENES AND IMMUNITY 4(3):175-176
Gregersen PK; Brehrens TW Fine mapping them phenotype in autoimmune disease: the promise and pitfalls of DNA microarray technologies | 0 | 0 |
| 46 | 1 | 33 | 46 2003 GENES CHROMOSOMES & CANCER 38(4):382-388
Bellacosa A Genetic hits and mutation rate in colorectal tumorigenesis: Versatility of Knudson's theory and implications for cancer prevention | 0 | 0 |
| 47 | 2 | 60 | 47 2003 GENETICS IN MEDICINE 5(4):261-268
Khoury MJ Genetics and genomics in practice: The continuum from genetic disease to genetic information in health and disease | 1 | 2 |
| 48 | 1 | 12 | 48 2003 GENOME BIOLOGY 4(11):-
Erle DJ; Yang YH Asthma investigators begin to reap the fruits of genomics | 0 | 0 |
| 49 | 1 | 12 | 49 2003 HUMAN MOLECULAR GENETICS 12():R153-R157
Nevins JR; Huang ES; Dressman H; Pittman J; Huang AT; West M Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction | 0 | 0 |
| 50 | 1 | 25 | 50 2003 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 18(2):123-129
Sorbello V; Fuso L; Sfiligoi C; Scafoglio C; Ponzone R; Biglia N; Weisz A; Sismondi P; De Bortoli M Quantitative real-time RT-PCR analysis of eight novel estrogen-regulated genes in breast cancer | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 51 | 1 | 46 | 51 2003 INTERNATIONAL JOURNAL OF CANCER 107(5):854-862
Ginestier C; Bardou VJ; Popovici C; Charafe-Jauffret E; Bertucci F; Geneix J; Adelaide J; Chaffanet M; Hassoun J; Viens P; Jacquemier J; Birnbaum D Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer | 0 | 0 |
| 52 | 1 | 99 | 52 2003 JOURNAL OF CLINICAL ONCOLOGY 21(17):3357-3365
Goldhirsch A; Wood WC; Gelber RD; Coates AS; Thurlimann B; Senn HJ Meeting highlights: Updated international expert consensus on the primary therapy of early breast cancer | 1 | 8 |
| 53 | 1 | 29 | 53 2003 JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY 56(4):198-204
Packeisen J; Korsching E; Herbst H; Boecker W; Buerger H Demystified ... Tissue microarray technology | 0 | 0 |
| 54 | 1 | 47 | 54 2003 JOURNAL OF HEPATOLOGY 39(6):1004-1012
Kurokawa Y; Matoba R; Takemasa I; Nakamori S; Tsujie M; Nagano H; Dono K; Umeshita K; Sakon M; Ueno N; Kita H; Oba S; Ishii S; Kato K; Monden M Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study | 0 | 0 |
| 55 | 1 | 105 | 55 2003 JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA 8(1):75-89
Fackler MJ; Evron E; Khan SA; Sukumar S Novel agents for chemoprevention, screening methods, and sampling issues | 0 | 0 |
| 56 | 2 | 90 | 56 2003 JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA 8(3):257-268
Jacobsen BM; Richer JK; Sartorius CA; Horwitz KB Expression profiling of human breast cancers and gene regulation by progesterone receptors | 0 | 0 |
| 57 | 1 | 73 | 57 2003 JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA 8(3):335-345
Fuller AP; Palmer-Toy D; Erlander MG; Sgroi DC Laser capture microdissection and advanced molecular analysis of human breast cancer | 0 | 0 |
| 58 | 1 | 95 | 58 2003 JOURNAL OF MEDICAL GENETICS 40(8):553-559
Bomprezzi R; Kovanen PE; Martin R New approaches to investigating heterogeneity in complex traits | 0 | 0 |
| 59 | 1 | 65 | 59 2003 JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 14():S271-S278
Susztak K; Sharma K; Schiffer M; McCue P; Ciccone E; Bottinger EP Genomic strategies for diabetic nephropathy | 0 | 0 |
| 60 | 1 | 7 | 60 2003 JOURNAL OF THE NATIONAL CANCER INSTITUTE 95(11):829-829
Pfeffer U; Noonan D; Albini A Microarray studies challenge theories of metastasis - Correspondence | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 61 | 1 | 31 | 61 2003 KLINISCHE PADIATRIE 215(3):135-138
Staege MS; Hattenhorst UE; Neumann I; Hutter C; Foja S; Burdach S DNA-microarrays as tools for the Identification of tumor specific gene expression profiles: Applications in tumor biology, diagnosis and therapy | 0 | 0 |
| 62 | 1 | 14 | 62 2003 LANCET 361(9369):1576-1577
Ramaswamy S; Perou CM DNA microarrays in breast cancer: the promise of personalised medicine | 2 | 4 |
| 63 | 1 | 33 | 63 2003 LANCET 362(9381):362-369
Chang JC; Wooten EC; Tsimelzon A; Hilsenbeck SG; Gutierrez MC; Elledge R; Mohsin S; Osborne CK; Chamness GC; Allred DC; O'Connell P Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer | 4 | 5 |
| 64 | 1 | 17 | 64 2003 LEUKEMIA 17(6):1183-1185
Schiller GJ Myelodysplasia - therapeutic response to novel therapy and the need for new diagnostic groups | 0 | 0 |
| 65 | 1 | 7 | 65 2003 M S-MEDECINE SCIENCES 19(11):1050-1051
Raguenez G; Benard J Molecular signature for cancer metastasis | 0 | 0 |
| 66 | 4 | 75 | 66 2003 MOLECULAR & CELLULAR PROTEOMICS 2(6):369-377
Celis JE; Gromov P; Gromova I; Moreira JMA; Cabezon T; Ambartsumian N; Grigorian M; Lukanidin E; Straten PT; Guldberg P; Bartkova J; Bartek J; Lukas J; Lukas C; Lykkesfeldt A; Jaattela M; Roepstorff P; Bolund L; Orntoft T; Brunner N; Overgaard J; Sandelin K; Blichert-Toft M; Mouridsen H; Rank FE Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research | 2 | 3 |
| 67 | 1 | 60 | 67 2003 NATURE 422(6928):226-232
Hanash S Disease proteomics | 1 | 26 |
| 68 | 1 | 108 | 68 2003 NATURE GENETICS 33():238-244
Balmain A; Gray J; Ponder B The genetics and genomics of cancer | 0 | 18 |
| 69 | 1 | 162 | 69 2003 NATURE GENETICS 34(4):369-376
Albertson DG; Collins C; McCormick F; Gray JW Chromosome aberrations in solid tumors | 0 | 2 |
| 70 | 2 | 10 | 70 2003 NATURE MEDICINE 9(8):999-1000
Van't Veer LJ; Weigelt B Road map to metastasis | 0 | 2 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 71 | 1 | 2 | 71 2003 NATURE REVIEWS CANCER 3(2):82-83
Hutchinson E Prediction power | 0 | 0 |
| 72 | 1 | 167 | 72 2003 NATURE REVIEWS CANCER 3(4):253-266
Laird PW The power and the promise of DNA methylation markers | 1 | 11 |
| 73 | 1 | 58 | 73 2003 NATURE REVIEWS CANCER 3(4):297-303
Pollak MN; Foulkes WD Challenges to cancer control by screening | 0 | 4 |
| 74 | 1 | 101 | 74 2003 NATURE REVIEWS CANCER 3(6):434-443
Perez-Losada J; Balmain A Stem-cell hierarchy in skin cancer | 0 | 6 |
| 75 | 1 | 30 | 75 2003 NATURE REVIEWS CANCER 3(7):540-545
Millar AW; Lynch KP Opinion - Rethinking clinical trials for cytostatic drugs | 0 | 0 |
| 76 | 1 | 78 | 76 2003 NATURE REVIEWS CANCER 3(12):912-920
Ulrich CM; Robien K; McLeod HL Cancer pharmacogenetics: Polymorphisms, pathways and beyond | 1 | 1 |
| 77 | 1 | 166 | 77 2003 NATURE REVIEWS DRUG DISCOVERY 2(7):566-580
Frank R; Hargreaves R Clinical biomarkers in drug discovery and development | 0 | 1 |
| 78 | 1 | 73 | 78 2003 NATURE REVIEWS GENETICS 4(6):409-418
Strausberg RL; Simpson AJG; Wooster R Sequence-based cancer genomics: Progress, lessons and opportunities | 0 | 2 |
| 79 | 1 | 109 | 79 2003 NATURE REVIEWS MOLECULAR CELL BIOLOGY 4(12):915-925
Birchmeier C; Birchmeier W; Gherardi E; Vande Woude GF Met, metastasis, motility and more | 0 | 0 |
| 80 | 1 | 4 | 80 2003 NEW ENGLAND JOURNAL OF MEDICINE 348(17):1715-1715
Helmbold P; Haerting J; Kolbl H Gene-expression signatures in breast cancer | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 81 | 1 | 58 | 81 2003 NEW ENGLAND JOURNAL OF MEDICINE 348(23):2339-2347
Wooster R; Weber BL Breast and ovarian cancer | 1 | 4 |
| 82 | 2 | 29 | 82 2003 NEW ENGLAND JOURNAL OF MEDICINE 349(10):996-998
Guttmacher AE; Collins FS Welcome to the genomic era | 0 | 1 |
| 83 | 1 | 183 | 83 2003 ONCOGENE 22(37):5915-5925
Haffty BG; Glazer PM Molecular markers in clinical radiation oncology | 0 | 0 |
| 84 | 1 | 142 | 84 2003 ONCOGENE 22(42):6524-6536
Bogenrieder T; Herlyn M Axis of evil: molecular mechanisms of cancer metastasis | 0 | 1 |
| 85 | 1 | 32 | 85 2003 ONCOLOGIST 8(3):252-258
Pusztai L; Ayers M; Stec J; Hortobagyi GN Clinical application of cDNA microarrays in oncology | 1 | 3 |
| 86 | 2 | 60 | 86 2003 ONKOLOGIE 26(5):438-445
Thomssen C; Janicke F; Harbeck N Clinical relevance of prognostic factors in axillary node-negative breast cancer | 0 | 1 |
| 87 | 1 | 23 | 87 2003 PATHOLOGY RESEARCH AND PRACTICE 199(6):419-423
Hergenhahn M; Kenzelmann M; Grone HJ Laser-controlled microdissection of tissues opens a window of new opportunities | 0 | 0 |
| 88 | 1 | 27 | 88 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(14):8418-8423
Sorlie T; Tibshirani R; Parker J; Hastie T; Marron JS; Nobel A; Deng S; Johnsen H; Pesich R; Geisler S; Demeter J; Perou CM; Lonning PE; Brown PO; Borresen-Dale AL; Botstein D Repeated observation of breast tumor subtypes in independent gene expression data sets | 0 | 7 |
| 89 | 1 | 25 | 89 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(18):10393-10398
Sotiriou C; Neo SY; McShane LM; Korn EL; Long PM; Jazaeri A; Martiat P; Fox SB; Harris AL; Liu ET Breast cancer classification and prognosis based on gene expression profiles from a population-based study | 0 | 1 |
| 90 | 1 | 29 | 90 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(19):10931-10936
Porter D; Weremowicz S; Chin K; Seth P; Keshaviah A; Lahti-Domenici J; Bae YK; Monitto CL; Merlos-Suarez A; Chan J; Hulette CM; Richardson A; Morton CC; Marks J; Duyao M; Hruban R; Gabrielson E; Gelman R; Polyak K A neural survival factor is a candidate oncogene in breast cancer | 0 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 91 | 1 | 27 | 91 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(26):15901-15905
Weigelt B; Glas AM; Wessels LFA; Witteveen AT; Peterse JL; van't Veert LJ Gene expression profiles of primary breast tumors maintained in distant metastases | 0 | 0 |
| 92 | 1 | 66 | 92 2003 PROSTATE 57(4):298-308
Witte JS; Suarez BK; Thiel B; Lin J; Yu A; Banerjee TK; Burmester JK; Casey G; Catalona WJ Genome-wide scan of brothers: Replication and fine mapping of prostate cancer susceptibility and aggressiveness loci | 0 | 1 |
| 93 | 1 | 41 | 93 2003 PROTEOMICS 3(10):1863-1873
Somiari RI; Sullivan A; Russell S; Somiari S; Hu H; Jordan R; George A; Katenhusen R; Buchowiecka A; Arciero C; Brzeski H; Hooke J; Shriver C High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast | 0 | 0 |
| 94 | 1 | 72 | 94 2003 RADIOTHERAPY AND ONCOLOGY 69(2):121-125
Baumann M; Holscher T; Begg AC Towards genetic prediction of radiation responses: ESTRO's GENEPI project | 0 | 0 |
| 95 | 1 | 12 | 95 2003 SCIENCE 299(5613):1679-1680
Ransohoff DF Developing molecular biomarkers for cancer | 0 | 1 |
| 96 | 1 | 79 | 96 2003 SEMINARS IN ONCOLOGY 30(6):740-748
Matesich SMA; Shapiro CL Second cancers after breast cancer treatment | 0 | 0 |
| 97 | 1 | 111 | 97 2003 TECHNOLOGY IN CANCER RESEARCH & TREATMENT 2(6):491-504
Sokolov K; Aaron J; Hsu B; Nida D; Gillenwater A; Follen M; MacAulay C; Adler-Storthz K; Korgel B; Descour M; Pasqualini R; Arap W; Lam W; Richards-Kortum R Optical systems for In vivo molecular imaging of cancer | 0 | 0 |
| 98 | 1 | 20 | 98 2003 THROMBOSIS AND HAEMOSTASIS 90(3):538-548
Look M; van Putten W; Duffy M; Harbeck N; Christensen IJ; Thomssen C; Kates R; Spyratos F; Ferno M; Eppenberger-Castori S; Sweep CGJF; Ulm K; Peyrat JP; Martin PM; Magdelenat H; Brunner N; Duggan C; Lisboa BW; Bendah PO; Quillien V; Daver A; Ricolleau G; Meijer-Van Gelder M; Manders P; Fiets WE; Blankenstein M; Broet P; Romain S; Daxenbichler G; Windbichler G; Cufer T; Borstnar S; Kueng W; Beex L; Klijn J; O'Higgins N; Eppenberger U; Janicke F; Schmitt M; Foekens J Pooled analysis of prognostic impact of uPA and PAI-I in breast cancer patients | 0 | 0 |
| 99 | 2 | 75 | 99 2003 TISSUE ANTIGENS 62(2):93-103
Boussioutas A; Haviv I Current and potential uses for DNA microarrays in transplantation medicine: lessons from other disciplines | 0 | 0 |
| 100 | 1 | 46 | 100 2003 TRENDS IN CARDIOVASCULAR MEDICINE 13(4):163-168
Patino WD; Mian OY; Shizukuda Y; Hwang PM Current and future applications of SAGE to cardiovascular medicine | 0 | 2 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | GCS |
| 101 | 1 | 18 | 101 2003 TUMORI ():S122-S123
Tagliaferri P; Tassone P; Salvino A; Barbieri V; Masciari S; Grillone F; Venuta S Debate over adjuvant and neoadjuvant chemotherapy | 0 | 0 |
| 102 | 2 | 36 | 102 2004 AMERICAN JOURNAL OF PATHOLOGY 164(1):35-42
Cronin M; Pho M; Dutta D; Stephans JC; Shak S; Kiefer MC; Esteban JM; Baker JB Measurement of gene expression in archival paraffin-embedded tissues - Development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay | 0 | 0 |
| 103 | 2 | 59 | 103 2004 ANNALS OF SURGICAL ONCOLOGY 11(1):3S-8S
Esserman L Neoadjuvant chemotherapy for primary breast cancer: Lessons learned and opportunities to optimize therapy | 0 | 0 |
| 104 | 3 | 33 | 104 2004 DRUG DISCOVERY TODAY 9(2):S53-S56
Hegde PS; White IR; Debouck C Interplay of transcriptomics and proteomics | 0 | 0 |
| 105 | 2 | 43 | 105 2004 GENETICS IN MEDICINE 6(1):38-47
Khoury MJ; Yang QH; Gwinn M; Little JL; Flanders WD An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions | 0 | 0 |
| 106 | 2 | 43 | 106 2004 JOURNAL OF APPLIED MICROBIOLOGY 96(1):18-23
Campbell CJ; Ghazal P Molecular signatures for diagnosis of infection: application of microarray technology | 0 | 0 |
| 107 | 2 | 45 | 107 2004 JOURNAL OF NEUROSCIENCE METHODS 132(1):57-68
Parrish ML; Wei N; Duenwald S; Tokiwa GY; Wang YQ; Holder D; Dai HY; Zhang XH; Wright C; Hodor P; Cavet G; Phillips RL; Sun BI; Fare TL A microarray platform comparison for neuroscience applications | 0 | 0 |
| 108 | 1 | 74 | 108 2004 LANCET ONCOLOGY 5(1):27-36
Swanton C Cell-cycle targeted therapies | 0 | 0 |
| 109 | 1 | 45 | 109 2004 MAMMALIAN GENOME 15(1):1-13
Symula DJ; Zhu YW; Schimenti JC; Rubin EM Functional annotation of mouse mutations in embryonic stem cells by use of expression profiling | 0 | 0 |
| 110 | 2 | 18 | 110 2004 PHARMACOGENOMICS 5(1):9-13
Mansmann U How to understand a complex reality: statistical issues in microarray experiments | 0 | 0 |
Generated by: HistCite(Vlad).
Version: 2004.01.07